Lactoferrin vs Vilon
A side-by-side research comparison of Lactoferrin and Vilon across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Lactoferrin | Vilon |
|---|---|---|
| Full name | Lactoferrin (Iron-Binding Glycoprotein) | Vilon (Lys-Glu Dipeptide Immune Bioregulator) |
| Category | Immune Support | Immune Support |
| Status | Dietary supplement (GRAS) | Research compound (peptide bioregulator) |
| Mechanism | Sequesters iron from pathogens (bacteriostatic), directly disrupts bacterial membranes, activates NK cells and macrophages, and modulates inflammatory cytokines. | As a very short signal peptide (Lys-Glu), it is proposed to bind DNA and modulate gene expression in immune and other tissues, influencing chromatin activity, cytokine balance, and cellular aging markers. |
| Molecular weight | 80000 Da | ~275 Da |
| Half-life | ~4-8 hours (oral absorption of fragments) | Short (peptide) |
| Bioavailability | ~15-25% (oral, as bioactive fragments) | Oral (encapsulated) or subcutaneous |
| Typical dose | 200-600 mg | ~1-2 capsules/day or short injectable courses |
| Frequency | 1-2x daily | Once daily |
| Route | Oral capsule or powder | Oral capsule or subcutaneous |
Lactoferrin reported benefits
- Broad antimicrobial activity
- Iron homeostasis regulation
- Gut immune support
- Anti-biofilm properties
- Prebiotic effects
Vilon reported benefits
- Immune regulation support
- Gene-expression modulation (proposed)
- Anti-aging tissue effects (proposed)
- Short course-based protocol
Related comparisons
Research and educational reference only. Not medical advice.